After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Medical Instruments & Supplies industry segment. The current market capitalization of Resmed Inc is $33.99B. A total of 0.6 million shares were traded on the day, compared to an average of 933.68K shares.
In the most recent transaction, Sandercock Brett sold 1,000 shares of RMD for 244.23 per share on Dec 09 ’24. After the transaction, the Chief Financial Officer now owns 93,864 company shares. In a previous transaction on Dec 09 ’24, Sandercock Brett bought 1,000 shares at 244.23 per share.
Among the insiders who sold shares, FARRELL PETER C disposed of 2,000 shares on Dec 04 ’24 at a per-share price of $245.65. This resulted in the Director holding 81,218 shares of RMD after the transaction. In another insider transaction, FARRELL PETER C bought 2,000 shares at $250.00 per share on Dec 04 ’24.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Resmed Inc pays an annual dividend of $2.02, resulting in a dividend yield of 0.87%, and it has a price to earnings (P/E) ratio of 30.70. RMD’s most recent ex-dividend date was 0.8% when it declared a $0.53 quarterly dividend that was paid in cash on 11/7/2024. Previously, the company paid the dividend on 8/15/2024 with an ex-dividend date of 0.9%. The RMD stock dividend was $0.53 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, RMD has a high of $260.49 and a low of $164.12.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $35.39, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 3.71.
